Eye Care

Unlike most other OTC categories, in which marketing activities targeted not only the pharmaceuticals community, but also consumers, this was not previously the case in eye care. Companies would reach out to doctors and to chemists/pharmacists in…

Over the review period, eye care continued to benefit from the growing demand for products that can soothe eye fatigue, which is mainly resulting from extended exposure to digital devices, mainly computers, smartphones, TVs and tablets. Sales…

Vision disorders continue to increase in France, stemming from greater exposure to digital screens and a decrease in the time spent outdoors. Post-pandemic, working from home has become a permanent measure for many former office-based employees, at…

Eye care sales are set to rise in 2023. The increasing use of digital screens for both work and leisure, with smartphones becoming ever more central to virtually every area of consumers’ lifestyles, is driving up the prevalence of a variety of eye…

Eye care is expected to register an increase in both current value and volume sales in 2023, partly as a result of rising inflation due to the ongoing war in Ukraine, which is driving up retail prices. In addition, local consumers spend more time…

Longer and stronger periods of pollen and increasing cases of allergies is boosting sales of eye care, primarily allergy eye care. Sales of these products have benefited from high pollen levels in Belgium in the early months of 2023 due to the…

Elevated inflation and spiralling manufacturing costs has led to further price increases within eye care in Austria which has helped to support current value growth in 2023 but has led to a significant decline in retail volume terms. Despite seeing…